Symptom-Based Markers for COVID-19 Transmission
Part of paid clinical trials in Iowa City, Iowa.
- Sponsor
- University of Iowa
- Study ID
- NCT04665245
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Not accepted
Study Details
In this study, COVID-19 positive patients will be added to a bidirectional texting program to receive daily surveys about their symptoms with the infection. This data will further the understanding of COVID-19 symptom development throughout the infection period, as well as how those symptoms vary at different points of the day. This study will be a single cohort, observational study of COVID-19 patients.
Key Dates
- Start date
- Dec 15, 2020
- Status verified
- Jan 2026
- Primary completion
- May 19, 2021
- Completion
- May 19, 2021
Study Design
- Enrollment
- 214 participants (actual)
Arms
- Arm: COVID-19 Positive PatientsThe study only includes one cohort: COVID-19 positive patients. Enrollees will not receive any therapeutic intervention; participants will simply report their temperature and any symptoms experienced twice per day for 10 days.
Primary Outcome Measure
Body Temperature [ Time Frame: 10 days ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Iowa Hospitals & Clinics | Iowa City | Iowa | 52242 | - |
Find similar trials in Iowa City, IA
By condition
By specialty
By research site
Related Studies
- Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory FailurePHASE2 · Recruiting · Jon Simmons · Mobile, Alabama
- COVID-19 Survivorship RegistryRecruiting · NYU Langone Health · New York, New York
- Defibrotide for the Treatment of Severe COVID-19PHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology EfficacyRecruiting · Aventyn, Inc. · Phoenix, Arizona